GeneLoc Integrated Map for Chromosome 17: Search Results

# #	Location Location	Strand Strand	Gene Gene	Enhancer ID Enhancer ID	Unigene cluster Unigene cluster	Entrez Gene Id Entrez Gene Id	Ensembl Id Ensembl Id	Description Description
1	chr17: 3,499,389-3,501,001			GH17J003499
2	chr17: 3,502,587-3,502,736			GH17J003502
3	chr17: 3,503,477-3,504,445			GH17J003503
4	chr17: 3,510,167-3,510,316			GH17J003510
5	chr17: 3,510,502-3,557,995	-	TRPV3 Exon structure		Hs.446255	162514	ENSG00000167723	transient receptor potential cation channel subfamily V member 3
6	chr17: 3,511,768-3,513,932			GH17J003511
7	chr17: 3,511,986-3,537,450	-	GC17M003518
8	chr17: 3,512,751-3,512,777	-	PIR41418 Exon structure
9	chr17: 3,514,269-3,515,542			GH17J003514
10	chr17: 3,516,243-3,517,015			GH17J003516
11	chr17: 3,518,361-3,519,853			GH17J003518
12	chr17: 3,520,848-3,521,764			GH17J003520
13	chr17: 3,523,464-3,525,141			GH17J003523
14	chr17: 3,528,491-3,532,326			GH17J003528
15	chr17: 3,534,676-3,537,003			GH17J003534
16	chr17: 3,542,248-3,543,141			GH17J003542
17	chr17: 3,546,335-3,547,230			GH17J003546
18	chr17: 3,550,122-3,550,412			GH17J003550
19	chr17: 3,556,591-3,559,706			GH17J003556
20	chr17: 3,562,473-3,563,683			GH17J003562
21	chr17: 3,565,444-3,609,411	-	TRPV1 Exon structure		Hs.655380	7442	ENSG00000196689	transient receptor potential cation channel subfamily V member 1
22	chr17: 3,574,163-3,576,390			GH17J003574
23	chr17: 3,577,955-3,578,853	-	ENSG00000263338 Exon structure				ENSG00000263338
24	chr17: 3,580,488-3,580,514	-	PIR44716 Exon structure
25	chr17: 3,585,149-3,636,249	-	ENSG00000262304 Exon structure				ENSG00000262304
26	chr17: 3,593,160-3,593,219			GH17J003593
27	chr17: 3,593,667-3,595,648			GH17J003594
28	chr17: 3,597,065-3,597,124			GH17J003597
29	chr17: 3,601,761-3,602,272	-	ENSG00000261916 Exon structure				ENSG00000261916
30	chr17: 3,603,210-3,604,058			GH17J003603
31	chr17: 3,608,262-3,636,322	-	SHPK Exon structure		Hs.579217	23729	ENSG00000197417	sedoheptulokinase
32	chr17: 3,619,256-3,619,913	-	LOC100422717 Exon structure			100422717	ENSG00000262248
33	chr17: 3,627,064-3,628,050			GH17J003627
34	chr17: 3,631,519-3,631,541			GH17J003631
35	chr17: 3,634,583-3,637,601			GH17J003634
36	chr17: 3,636,468-3,663,103	+	CTNS Exon structure		Hs.187667	1497	ENSG00000040531	cystinosin, lysosomal cystine transporter
37	chr17: 3,639,602-3,642,424			GH17J003639
38	chr17: 3,643,109-3,651,755	-	LOC105371493 Exon structure			105371493
39	chr17: 3,647,867-3,648,587			GH17J003647
40	chr17: 3,652,550-3,658,092	-	LOC105371492 Exon structure			105371492	ENSG00000262903
41	chr17: 3,657,477-3,661,589			GH17J003657
42	chr17: 3,661,847-3,662,131			GH17J003661
43	chr17: 3,662,237-3,662,866			GH17J003662
44	chr17: 3,662,893-3,696,404	-	P2RX5-TAX1BP3 Exon structure			100533970	ENSG00000257950	P2RX5-TAX1BP3 readthrough (NMD candidate)
45	chr17: 3,662,893-3,668,682	-	TAX1BP3 Exon structure		Hs.12956	30851	ENSG00000213977	Tax1 binding protein 3
46	chr17: 3,663,192-3,663,251			GH17J003663
47	chr17: 3,663,556-3,663,615			GH17J003666
48	chr17: 3,664,084-3,665,260			GH17J003664
49	chr17: 3,665,176-3,665,225	+	GC17P003666
50	chr17: 3,665,176-3,665,225	+	GC17P003667
51	chr17: 3,665,176-3,665,225	+	GC17P003669
52	chr17: 3,665,177-3,665,740	+	RPL21P125 Exon structure			100129685	ENSG00000240898	ribosomal protein L21 pseudogene 125
53	chr17: 3,665,838-3,670,016			GH17J003665
54	chr17: 3,668,723-3,669,669	+	EMC6 Exon structure		Hs.30011	83460	ENSG00000127774	ER membrane protein complex subunit 6
55	chr17: 3,672,199-3,696,404	-	P2RX5 Exon structure		Hs.731607	5026	ENSG00000083454	purinergic receptor P2X 5
56	chr17: 3,678,067-3,678,216			GH17J003678
57	chr17: 3,681,491-3,683,496			GH17J003681
58	chr17: 3,683,760-3,683,956			GH17J003683
59	chr17: 3,688,034-3,688,093			GH17J003688
60	chr17: 3,689,801-3,690,000			GH17J003689
61	chr17: 3,690,078-3,698,219			GH17J003690
62	chr17: 3,710,418-3,713,566			GH17J003710
63	chr17: 3,714,625-3,801,243	-	ITGAE Exon structure		Hs.513867	3682	ENSG00000083457	integrin subunit alpha E
64	chr17: 3,719,292-3,721,761			GH17J003719
65	chr17: 3,721,628-3,722,488	+	ENSG00000262692 Exon structure				ENSG00000262692
66	chr17: 3,722,504-3,725,173			GH17J003722
67	chr17: 3,723,903-3,726,699	+	HASPIN Exon structure		Hs.534059	83903	ENSG00000177602	histone H3 associated protein kinase
68	chr17: 3,724,742-3,724,771	+	PIR47216 Exon structure
69	chr17: 3,725,211-3,725,239	+	PIR39862 Exon structure
70	chr17: 3,727,167-3,727,316			GH17J003727
71	chr17: 3,729,361-3,730,493	+	ENSG00000262358 Exon structure				ENSG00000262358
72	chr17: 3,730,602-3,731,329			GH17J003730
73	chr17: 3,732,201-3,732,600			GH17J003732
74	chr17: 3,737,307-3,741,562			GH17J003737
75	chr17: 3,742,679-3,743,813			GH17J003742
76	chr17: 3,743,879-3,745,233			GH17J003743
77	chr17: 3,745,616-3,746,283			GH17J003745
78	chr17: 3,747,585-3,749,358			GH17J003747
79	chr17: 3,750,530-3,751,779			GH17J003750
80	chr17: 3,751,919-3,752,546			GH17J003751
81	chr17: 3,753,333-3,754,139			GH17J003753
82	chr17: 3,754,292-3,756,106			GH17J003754
83	chr17: 3,759,169-3,760,497			GH17J003759
84	chr17: 3,760,715-3,761,761			GH17J003760
85	chr17: 3,762,941-3,767,222			GH17J003762
86	chr17: 3,768,918-3,769,180			GH17J003768
87	chr17: 3,769,923-3,771,486			GH17J003769
88	chr17: 3,771,967-3,772,116			GH17J003771
89	chr17: 3,772,907-3,773,056			GH17J003772
90	chr17: 3,773,600-3,773,801			GH17J003773
91	chr17: 3,777,188-3,778,417			GH17J003777
92	chr17: 3,780,843-3,781,532			GH17J003780
93	chr17: 3,788,307-3,788,456			GH17J003788
94	chr17: 3,789,718-3,790,357			GH17J003789
95	chr17: 3,790,401-3,790,800			GH17J003790
96	chr17: 3,791,400-3,792,200			GH17J003791
97	chr17: 3,792,477-3,793,075			GH17J003792
98	chr17: 3,793,277-3,793,987			GH17J003793
99	chr17: 3,794,257-3,797,136			GH17J003794
100	chr17: 3,798,002-3,806,070			GH17J003798
101	chr17: 3,802,160-3,846,251	-	NCBP3 Exon structure		Hs.120963	55421	ENSG00000074356	nuclear cap binding subunit 3
102	chr17: 3,806,748-3,808,854	-	GC17M003807
103	chr17: 3,808,267-3,809,788			GH17J003808
104	chr17: 3,809,199-3,809,230	-	PIR46371 Exon structure
105	chr17: 3,809,199-3,809,230	-	GC17M003810
106	chr17: 3,811,029-3,811,056	-	PIR42093 Exon structure
107	chr17: 3,811,136-3,811,166	-	PIR49371 Exon structure
108	chr17: 3,811,136-3,811,166	-	GC17M003812
109	chr17: 3,812,195-3,813,978			GH17J003812
110	chr17: 3,818,401-3,819,304			GH17J003818
111	chr17: 3,825,066-3,825,083	+	GC17P003825
112	chr17: 3,827,247-3,827,416			GH17J003827
113	chr17: 3,827,747-3,829,764			GH17J003828
114	chr17: 3,828,758-3,829,811	+	GC17P003828
115	chr17: 3,833,250-3,836,302			GH17J003833
116	chr17: 3,837,371-3,840,199			GH17J003837
117	chr17: 3,844,047-3,844,196			GH17J003845
118	chr17: 3,844,932-3,846,956			GH17J003844
119	chr17: 3,857,807-3,857,956			GH17J003857
120	chr17: 3,859,886-3,861,130			GH17J003859
121	chr17: 3,860,315-3,894,891	-	CAMKK1 Exon structure		Hs.8417	84254	ENSG00000004660	calcium/calmodulin dependent protein kinase kinase 1
122	chr17: 3,866,664-3,866,758			GH17J003866
123	chr17: 3,870,700-3,871,400			GH17J003870
124	chr17: 3,878,847-3,880,634			GH17J003878
125	chr17: 3,885,071-3,896,001			GH17J003885
126	chr17: 3,894,522-3,902,961	+	GC17P003894
127	chr17: 3,896,060-3,897,176			GH17J003896
128	chr17: 3,896,591-3,916,666	-	P2RX1 Exon structure		Hs.41735	5023	ENSG00000108405	purinergic receptor P2X 1
129	chr17: 3,900,414-3,901,200			GH17J003900
130	chr17: 3,901,340-3,902,022			GH17J003901
131	chr17: 3,903,573-3,905,560			GH17J003903
132	chr17: 3,905,106-3,911,845	-	GC17M003905
133	chr17: 3,907,627-3,907,776			GH17J003907
134	chr17: 3,910,326-3,912,300			GH17J003910
135	chr17: 3,913,401-3,919,199			GH17J003913
136	chr17: 3,920,872-3,922,425			GH17J003920
137	chr17: 3,923,869-3,964,464	-	ATP2A3 Exon structure		Hs.513870	489	ENSG00000074370	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
138	chr17: 3,924,095-3,928,937			GH17J003924
139	chr17: 3,925,884-3,938,275	-	GC17M003925
140	chr17: 3,929,273-3,931,643			GH17J003929
141	chr17: 3,934,687-3,935,601			GH17J003934
142	chr17: 3,938,726-3,941,716	+	GC17P003938
143	chr17: 3,944,599-3,945,538			GH17J003944
144	chr17: 3,956,527-3,956,676			GH17J003958
145	chr17: 3,956,787-3,956,936			GH17J003956
146	chr17: 3,957,768-3,958,635			GH17J003957
147	chr17: 3,959,060-3,968,077			GH17J003959
148	chr17: 3,968,127-3,968,258			GH17J003968
149	chr17: 3,968,909-3,969,815			GH17J003969
150	chr17: 3,970,832-3,971,484			GH17J003970
151	chr17: 3,972,401-3,972,800			GH17J003972
152	chr17: 3,973,052-3,973,549			GH17J003973
153	chr17: 3,973,913-3,975,094			GH17J003974
154	chr17: 3,976,341-3,979,436			GH17J003976
155	chr17: 3,977,060-3,983,089	+	LINC01975 Exon structure			105371496	ENSG00000263312	long intergenic non-protein coding RNA 1975
156	chr17: 3,977,084-3,983,613	+	GC17P003980
157	chr17: 3,980,186-3,980,796			GH17J003982
158	chr17: 3,980,987-3,981,693			GH17J003980
159	chr17: 3,981,988-3,982,830			GH17J003981
160	chr17: 3,983,802-3,984,531			GH17J003983
161	chr17: 3,985,617-3,986,570			GH17J003985
162	chr17: 3,988,469-3,989,479			GH17J003988
163	chr17: 3,989,094-3,989,619	-	GC17M003989
164	chr17: 3,990,244-3,991,737	-	GC17M003990
165	chr17: 4,001,927-4,005,488			GH17J004001
166	chr17: 4,004,445-4,143,020	-	ZZEF1 Exon structure		Hs.277624	23140	ENSG00000074755	zinc finger ZZ-type and EF-hand domain containing 1
167	chr17: 4,006,441-4,009,862			GH17J004006
168	chr17: 4,011,722-4,014,198	+	GC17P004011
169	chr17: 4,011,722-4,014,198	+	GC17P004012
170	chr17: 4,011,724-4,014,199	+	GC17P004013
171	chr17: 4,011,724-4,012,748	-	GC17M004011
172	chr17: 4,013,702-4,015,354			GH17J004013
173	chr17: 4,033,518-4,034,391			GH17J004033
174	chr17: 4,042,972-4,044,276			GH17J004042
175	chr17: 4,045,554-4,045,851			GH17J004045
176	chr17: 4,056,756-4,056,876	-	RNA5SP434 Exon structure			100873684	ENSG00000252456	RNA, 5S ribosomal pseudogene 434
177	chr17: 4,067,126-4,080,322	-	GC17M004067
178	chr17: 4,072,867-4,073,076			GH17J004072
179	chr17: 4,073,086-4,075,536			GH17J004073
180	chr17: 4,082,656-4,094,535	+	GC17P004083
181	chr17: 4,090,647-4,091,548			GH17J004090
182	chr17: 4,099,998-4,102,660			GH17J004099
183	chr17: 4,104,273-4,106,612			GH17J004104
184	chr17: 4,117,598-4,118,595			GH17J004117
185	chr17: 4,120,442-4,123,041			GH17J004120
186	chr17: 4,125,067-4,125,276			GH17J004125
187	chr17: 4,130,381-4,131,888			GH17J004130
188	chr17: 4,133,329-4,145,755			GH17J004133
189	chr17: 4,143,168-4,187,310	+	CYB5D2 Exon structure		Hs.513871	124936	ENSG00000167740	cytochrome b5 domain containing 2
190	chr17: 4,143,918-4,143,944	+	PIR51897 Exon structure
191	chr17: 4,152,276-4,153,236			GH17J004152
192	chr17: 4,159,138-4,160,753	+	GC17P004159
193	chr17: 4,159,356-4,164,867			GH17J004159
194	chr17: 4,160,938-4,160,967	+	PIR41779 Exon structure
195	chr17: 4,163,371-4,264,008	-	ANKFY1 Exon structure		Hs.696087	51479	ENSG00000185722	ankyrin repeat and FYVE domain containing 1
196	chr17: 4,163,910-4,164,713	+	ENSG00000263165 Exon structure				ENSG00000263165
197	chr17: 4,164,511-4,164,540	+	PIR36155 Exon structure
198	chr17: 4,164,721-4,164,747	-	PIR45602 Exon structure
199	chr17: 4,164,797-4,164,828	+	PIR35376 Exon structure
200	chr17: 4,164,797-4,164,828	+	GC17P004166
201	chr17: 4,164,886-4,164,912	-	PIR38586 Exon structure
202	chr17: 4,164,992-4,165,020	-	PIR53225 Exon structure
203	chr17: 4,165,009-4,165,103			GH17J004165
204	chr17: 4,167,589-4,168,416			GH17J004167
205	chr17: 4,169,035-4,169,063	-	PIR41558 Exon structure
206	chr17: 4,171,008-4,171,037	-	PIR61072 Exon structure
207	chr17: 4,172,472-4,172,498	+	PIR60246 Exon structure
208	chr17: 4,172,500-4,172,526	+	PIR35722 Exon structure
209	chr17: 4,174,587-4,180,062			GH17J004174
210	chr17: 4,177,882-4,180,436	-	GC17M004177
211	chr17: 4,178,791-4,178,818	+	PIR52300 Exon structure
212	chr17: 4,185,946-4,188,660			GH17J004185
213	chr17: 4,186,325-4,186,422	+	GC17P004187
214	chr17: 4,186,326-4,186,424	+	ENSG00000251812 Exon structure				ENSG00000251812
215	chr17: 4,186,460-4,188,869	-	GC17M004186
216	chr17: 4,188,744-4,190,207			GH17J004188
217	chr17: 4,192,723-4,192,749	-	PIR60261 Exon structure
218	chr17: 4,192,767-4,192,863	+	GC17P004192
219	chr17: 4,194,874-4,196,620			GH17J004194
220	chr17: 4,198,638-4,199,673			GH17J004198
221	chr17: 4,199,946-4,200,075			GH17J004199
222	chr17: 4,200,367-4,200,960	-	LOC100420060 Exon structure			100420060
223	chr17: 4,203,848-4,206,068			GH17J004203
224	chr17: 4,207,312-4,208,905			GH17J004207
225	chr17: 4,214,201-4,214,800			GH17J004214
226	chr17: 4,215,080-4,216,513			GH17J004215
227	chr17: 4,219,955-4,221,663			GH17J004219
228	chr17: 4,222,066-4,225,054	+	RYKP1 Exon structure			6260	ENSG00000263219	receptor-like tyrosine kinase pseudogene 1
229	chr17: 4,222,196-4,222,514			GH17J004222
230	chr17: 4,228,561-4,231,486			GH17J004228
231	chr17: 4,231,593-4,233,201			GH17J004231
232	chr17: 4,233,995-4,234,242			GH17J004233
233	chr17: 4,235,450-4,236,949			GH17J004235
234	chr17: 4,241,086-4,242,315			GH17J004241
235	chr17: 4,243,786-4,243,935			GH17J004243
236	chr17: 4,246,329-4,249,595			GH17J004246
237	chr17: 4,249,600-4,249,801			GH17J004249
238	chr17: 4,262,533-4,264,861			GH17J004262
239	chr17: 4,267,691-4,268,430	+	ENSG00000274363 Exon structure				ENSG00000274363
240	chr17: 4,269,217-4,366,674	-	UBE2G1 Exon structure		Hs.741319	7326	ENSG00000132388	ubiquitin conjugating enzyme E2 G1
241	chr17: 4,272,214-4,272,534			GH17J004272
242	chr17: 4,300,931-4,301,330			GH17J004300
243	chr17: 4,301,247-4,303,382	+	MFSD1P1 Exon structure			100313532	ENSG00000261868	major facilitator superfamily domain containing 1 pseudogene 1
244	chr17: 4,301,372-4,302,698	+	GC17P004302
245	chr17: 4,301,853-4,302,458			GH17J004301
246	chr17: 4,304,546-4,304,695			GH17J004304
247	chr17: 4,306,925-4,308,751			GH17J004306
248	chr17: 4,310,566-4,310,755			GH17J004310
249	chr17: 4,311,001-4,311,200			GH17J004311
250	chr17: 4,313,001-4,314,200			GH17J004313
251	chr17: 4,317,910-4,319,199			GH17J004317
252	chr17: 4,325,730-4,330,615			GH17J004325
253	chr17: 4,330,687-4,331,404	+	GC17P004330
254	chr17: 4,332,401-4,333,000			GH17J004332
255	chr17: 4,334,257-4,334,790	-	GC17M004334
256	chr17: 4,334,795-4,335,809			GH17J004334
257	chr17: 4,340,399-4,343,654			GH17J004340
258	chr17: 4,344,631-4,344,839			GH17J004344
259	chr17: 4,350,089-4,352,911			GH17J004350
260	chr17: 4,358,201-4,358,400			GH17J004358
261	chr17: 4,359,005-4,360,935			GH17J004359
262	chr17: 4,361,168-4,363,896			GH17J004361
263	chr17: 4,363,926-4,367,517			GH17J004363
264	chr17: 4,364,164-4,364,453	-	RN7SL774P Exon structure			106481761	ENSG00000263882	RNA, 7SL, cytoplasmic 774, pseudogene
265	chr17: 4,368,689-4,369,661	+	GC17P004368
266	chr17: 4,373,765-4,376,490			GH17J004373
267	chr17: 4,388,784-4,389,493			GH17J004388
268	chr17: 4,393,447-4,398,090			GH17J004393
269	chr17: 4,407,286-4,407,475			GH17J004408
270	chr17: 4,407,586-4,408,471			GH17J004407
271	chr17: 4,412,844-4,413,895			GH17J004412
272	chr17: 4,420,620-4,421,056			GH17J004420
273	chr17: 4,429,356-4,430,335			GH17J004429
274	chr17: 4,433,146-4,434,600			GH17J004433
275	chr17: 4,433,688-4,488,208	+	SPNS3 Exon structure		Hs.657543	201305	ENSG00000182557	sphingolipid transporter 3 (putative)
276	chr17: 4,436,134-4,437,611			GH17J004436
277	chr17: 4,440,319-4,440,880			GH17J004440
278	chr17: 4,441,066-4,441,215			GH17J004441
279	chr17: 4,441,426-4,441,575			GH17J004442
280	chr17: 4,441,454-4,441,483	+	PIR52974 Exon structure
281	chr17: 4,444,488-4,445,208			GH17J004444
282	chr17: 4,454,386-4,454,555			GH17J004454
283	chr17: 4,473,726-4,474,616			GH17J004473
284	chr17: 4,475,174-4,484,305			GH17J004475
285	chr17: 4,481,966-4,486,353	-	ENSG00000262823 Exon structure				ENSG00000262823
286	chr17: 4,484,598-4,484,908			GH17J004484
287	chr17: 4,485,601-4,487,000			GH17J004485
288	chr17: 4,487,273-4,488,575			GH17J004487
289	chr17: 4,489,500-4,494,015			GH17J004489
290	chr17: 4,496,708-4,497,184			GH17J004496
291	chr17: 4,497,394-4,499,674	-	ENSG00000229782 Exon structure				ENSG00000229782
292	chr17: 4,497,446-4,497,595			GH17J004497
293	chr17: 4,498,269-4,501,580			GH17J004498
294	chr17: 4,498,834-4,539,933	+	SPNS2 Exon structure		Hs.22824	124976	ENSG00000183018	sphingolipid transporter 2
295	chr17: 4,502,406-4,506,878			GH17J004502
296	chr17: 4,504,897-4,504,927	-	PIR54894 Exon structure
297	chr17: 4,504,897-4,504,927	-	GC17M004505
298	chr17: 4,507,536-4,508,239			GH17J004507
299	chr17: 4,509,006-4,510,400			GH17J004509
300	chr17: 4,510,057-4,524,575	+	GC17P004510
301	chr17: 4,510,061-4,524,577	+	GC17P004512
302	chr17: 4,510,714-4,512,100			GH17J004510
303	chr17: 4,511,177-4,525,135	+	GC17P004511
304	chr17: 4,512,822-4,516,025			GH17J004512
305	chr17: 4,516,390-4,517,514			GH17J004516
306	chr17: 4,517,031-4,517,057	-	PIR53941 Exon structure
307	chr17: 4,517,976-4,518,298			GH17J004517
308	chr17: 4,518,570-4,523,223			GH17J004518
309	chr17: 4,523,410-4,524,758			GH17J004523
310	chr17: 4,527,147-4,527,276			GH17J004527
311	chr17: 4,530,079-4,532,054			GH17J004530
312	chr17: 4,533,272-4,538,827			GH17J004533
313	chr17: 4,538,896-4,555,631	-	MYBBP1A Exon structure		Hs.701718	10514	ENSG00000132382	MYB binding protein 1a
314	chr17: 4,540,236-4,541,742			GH17J004540
315	chr17: 4,541,779-4,541,990			GH17J004541
316	chr17: 4,542,928-4,545,985			GH17J004542
317	chr17: 4,545,903-4,545,934	+	PIR35626 Exon structure
318	chr17: 4,545,903-4,545,934	+	GC17P004547
319	chr17: 4,546,389-4,546,415	+	PIR51445 Exon structure
320	chr17: 4,553,789-4,556,362			GH17J004553
321	chr17: 4,556,927-4,560,818	-	GGT6 Exon structure		Hs.130749	124975	ENSG00000167741	gamma-glutamyltransferase 6
322	chr17: 4,559,859-4,561,255			GH17J004559
323	chr17: 4,561,282-4,563,057			GH17J004561
324	chr17: 4,563,506-4,563,655			GH17J004563
325	chr17: 4,563,865-4,563,898	-	PIR54684 Exon structure
326	chr17: 4,563,865-4,563,897	-	GC17M004564
327	chr17: 4,563,867-4,563,898	-	GC17M004565
328	chr17: 4,565,402-4,566,146			GH17J004565
329	chr17: 4,565,752-4,571,760	+	ENSG00000262921 Exon structure				ENSG00000262921
330	chr17: 4,566,786-4,566,955			GH17J004566
331	chr17: 4,572,176-4,572,660	+	TXNP4 Exon structure			124974	ENSG00000262519	thioredoxin pseudogene 4
332	chr17: 4,572,206-4,572,515	+	GC17P004573
333	chr17: 4,573,706-4,573,855			GH17J004573
334	chr17: 4,574,423-4,575,301	-	GC17M004575
335	chr17: 4,575,469-4,577,881			GH17J004575
336	chr17: 4,583,432-4,589,752			GH17J004583
337	chr17: 4,583,981-4,608,319	+	SMTNL2 Exon structure		Hs.441709	342527	ENSG00000188176	smoothelin like 2
338	chr17: 4,590,110-4,594,365			GH17J004590
339	chr17: 4,594,373-4,595,791			GH17J004594
340	chr17: 4,597,603-4,601,787			GH17J004597
341	chr17: 4,602,654-4,611,702			GH17J004602
342	chr17: 4,610,449-4,617,650	+	LINC01996 Exon structure		Hs.434312	400568	ENSG00000261863	long intergenic non-protein coding RNA 1996
343	chr17: 4,612,171-4,613,119			GH17J004612
344	chr17: 4,615,378-4,619,027			GH17J004615
345	chr17: 4,616,764-4,629,907	-	LOC105371498 Exon structure			105371498
346	chr17: 4,619,749-4,619,852	-	RNU6-955P Exon structure			106480624	ENSG00000222429	RNA, U6 small nuclear 955, pseudogene
347	chr17: 4,624,350-4,626,195			GH17J004624
348	chr17: 4,626,847-4,628,115	+	GC17P004626
349	chr17: 4,630,902-4,642,294	-	ALOX15 Exon structure		Hs.73809	246	ENSG00000161905	arachidonate 15-lipoxygenase
350	chr17: 4,632,386-4,632,535			GH17J004632
351	chr17: 4,635,601-4,636,800			GH17J004635
352	chr17: 4,641,668-4,641,727			GH17J004641
353	chr17: 4,645,322-4,665,775	+	LOC105371499 Exon structure			105371499
354	chr17: 4,645,562-4,646,200			GH17J004645
355	chr17: 4,648,455-4,649,259	+	GC17P004648
356	chr17: 4,648,673-4,649,495			GH17J004648
357	chr17: 4,653,415-4,657,660	-	GC17M004653
358	chr17: 4,656,343-4,656,380	+	GC17P004656
359	chr17: 4,657,669-4,659,155			GH17J004657
360	chr17: 4,659,234-4,659,295			GH17J004659
361	chr17: 4,660,666-4,660,815			GH17J004660
362	chr17: 4,669,774-4,704,337	-	PELP1 Exon structure		Hs.744899	27043	ENSG00000141456	proline, glutamate and leucine rich protein 1
363	chr17: 4,672,987-4,674,804	+	GC17P004672
364	chr17: 4,673,830-4,696,831	+	ENSG00000235085 Exon structure				ENSG00000235085
365	chr17: 4,678,086-4,680,519			GH17J004678
366	chr17: 4,678,421-4,691,961	-	GC17M004678
367	chr17: 4,683,552-4,684,392			GH17J004683
368	chr17: 4,695,803-4,697,455			GH17J004695
369	chr17: 4,703,049-4,705,001			GH17J004703
370	chr17: 4,704,230-4,705,529	+	LOC101559451 Exon structure			101559451	ENSG00000244184
371	chr17: 4,704,799-4,705,299	-	RPS12P29 Exon structure			728244	ENSG00000213939	ribosomal protein S12 pseudogene 29
372	chr17: 4,704,816-4,705,217	-	GC17M004711
373	chr17: 4,706,020-4,706,628			GH17J004706
374	chr17: 4,708,602-4,708,775			GH17J004708
375	chr17: 4,709,266-4,713,371			GH17J004709
376	chr17: 4,710,489-4,721,500	+	ARRB2 Exon structure		Hs.435811	409	ENSG00000141480	arrestin beta 2
377	chr17: 4,713,716-4,716,473			GH17J004713
378	chr17: 4,714,417-4,728,624	-	GC17M004714
379	chr17: 4,719,443-4,720,376			GH17J004719
380	chr17: 4,720,567-4,722,495			GH17J004720
381	chr17: 4,721,655-4,722,251	-	GC17M004721
382	chr17: 4,724,802-4,726,800			GH17J004724
383	chr17: 4,725,849-4,726,054	+	GC17P004725
384	chr17: 4,727,666-4,728,864			GH17J004727
385	chr17: 4,730,298-4,732,315			GH17J004730
386	chr17: 4,731,408-4,733,610	+	MED11 Exon structure		Hs.513885	400569	ENSG00000161920	mediator complex subunit 11
387	chr17: 4,731,756-4,732,371	-	ENSG00000261898 Exon structure				ENSG00000261898
388	chr17: 4,732,886-4,734,083			GH17J004732
389	chr17: 4,733,526-4,739,928	-	CXCL16 Exon structure		Hs.745037	58191	ENSG00000161921	C-X-C motif chemokine ligand 16
390	chr17: 4,735,478-4,737,165			GH17J004735
391	chr17: 4,737,465-4,832,285	-	GC17M004737
392	chr17: 4,738,128-4,740,346			GH17J004738
393	chr17: 4,740,015-4,746,119	+	ZMYND15 Exon structure		Hs.47223	84225	ENSG00000141497	zinc finger MYND-type containing 15
394	chr17: 4,744,666-4,745,439			GH17J004744
395	chr17: 4,747,456-4,748,800			GH17J004747
396	chr17: 4,752,145-4,752,262			GH17J004752
397	chr17: 4,759,433-4,760,423			GH17J004759
398	chr17: 4,764,202-4,767,600			GH17J004764
399	chr17: 4,768,200-4,768,401			GH17J004768
400	chr17: 4,768,423-4,768,686			GH17J004770
401	chr17: 4,769,754-4,772,839			GH17J004769
402	chr17: 4,771,884-4,783,213	+	TM4SF5 Exon structure		Hs.184194	9032	ENSG00000142484	transmembrane 4 L six family member 5
403	chr17: 4,780,437-4,781,080			GH17J004780
404	chr17: 4,785,285-4,786,434	-	VMO1 Exon structure		Hs.122561	284013	ENSG00000182853	vitelline membrane outer layer 1 homolog
405	chr17: 4,786,093-4,791,385			GH17J004786
406	chr17: 4,787,057-4,789,162	+	ENSG00000280254 Exon structure				ENSG00000280254
407	chr17: 4,788,422-4,790,592	+	GLTPD2 Exon structure		Hs.131035	388323	ENSG00000182327	glycolipid transfer protein domain containing 2
408	chr17: 4,795,409-4,797,075			GH17J004795
409	chr17: 4,796,144-4,798,503	+	PSMB6 Exon structure		Hs.77060	5694	ENSG00000142507	proteasome subunit beta 6
410	chr17: 4,801,159-4,807,013	-	ENSG00000262165 Exon structure				ENSG00000262165
411	chr17: 4,801,202-4,801,581			GH17J004801
412	chr17: 4,806,400-4,807,987			GH17J004806
413	chr17: 4,807,096-4,823,434	+	PLD2 Exon structure		Hs.104519	5338	ENSG00000129219	phospholipase D2
414	chr17: 4,808,186-4,808,335			GH17J004808
415	chr17: 4,832,503-4,836,729			GH17J004832
416	chr17: 4,833,340-4,898,061	+	MINK1 Exon structure		Hs.443417	50488	ENSG00000141503	misshapen like kinase 1
417	chr17: 4,837,162-4,841,055			GH17J004837
418	chr17: 4,842,801-4,846,199			GH17J004842
419	chr17: 4,846,866-4,847,015			GH17J004846
420	chr17: 4,847,426-4,851,837			GH17J004847
421	chr17: 4,852,000-4,855,270			GH17J004852
422	chr17: 4,856,142-4,861,409			GH17J004856
423	chr17: 4,856,757-4,857,399	-	ATP6V0CP1 Exon structure			100132978	ENSG00000230201	ATPase H+ transporting V0 subunit c pseudogene 1
424	chr17: 4,858,111-4,882,982	-	GC17M004858
425	chr17: 4,863,010-4,863,563			GH17J004863
426	chr17: 4,864,591-4,865,155			GH17J004864
427	chr17: 4,871,144-4,880,605			GH17J004871
428	chr17: 4,875,626-4,875,910	+	GC17P004875
429	chr17: 4,881,306-4,881,958			GH17J004881
430	chr17: 4,882,066-4,882,235			GH17J004882
431	chr17: 4,882,975-4,883,316	+	RN7SL784P Exon structure			106481134	ENSG00000264113	RNA, 7SL, cytoplasmic 784, pseudogene
432	chr17: 4,883,867-4,887,148			GH17J004883
433	chr17: 4,889,126-4,889,335			GH17J004889
434	chr17: 4,893,222-4,895,142			GH17J004893
435	chr17: 4,895,906-4,895,975			GH17J004895
436	chr17: 4,896,146-4,896,315			GH17J004896
437	chr17: 4,897,769-4,903,128	-	CHRNE Exon structure		Hs.654535	1145	ENSG00000108556	cholinergic receptor nicotinic epsilon subunit
438	chr17: 4,898,311-4,904,315			GH17J004898
439	chr17: 4,898,891-4,899,000	-	GC17M004898
440	chr17: 4,898,891-4,899,000	-	GC17M004900
441	chr17: 4,899,418-4,905,329	+	C17orf107 Exon structure		Hs.579243	100130311	ENSG00000205710	chromosome 17 open reading frame 107
442	chr17: 4,908,030-4,910,589			GH17J004908
443	chr17: 4,911,529-4,911,588			GH17J004911
444	chr17: 4,913,974-4,914,369			GH17J004913
445	chr17: 4,919,437-4,921,063			GH17J004919
446	chr17: 4,932,063-4,932,411			GH17J004932
447	chr17: 4,932,275-4,935,030	+	GP1BA Exon structure		Hs.1472	2811	ENSG00000185245	glycoprotein Ib platelet subunit alpha
448	chr17: 4,934,001-4,934,800			GH17J004934
449	chr17: 4,936,489-4,936,641			GH17J004936
450	chr17: 4,937,130-4,940,251	-	SLC25A11 Exon structure		Hs.184877	8402	ENSG00000108528	solute carrier family 25 member 11
451	chr17: 4,937,795-4,952,239			GH17J004937
452	chr17: 4,940,008-4,945,222	+	RNF167 Exon structure		Hs.7158	26001	ENSG00000108523	ring finger protein 167
453	chr17: 4,945,650-4,949,086	-	PFN1 Exon structure		Hs.494691	5216	ENSG00000108518	profilin 1
454	chr17: 4,948,092-4,957,131	+	ENO3 Exon structure		Hs.224171	2027	ENSG00000108515	enolase 3
455	chr17: 4,948,388-4,948,530	-	GC17M004948
456	chr17: 4,948,388-4,948,530	-	GC17M004950
457	chr17: 4,952,601-4,954,400			GH17J004952
458	chr17: 4,956,766-4,956,935			GH17J004956
459	chr17: 4,959,226-4,967,872	-	SPAG7 Exon structure		Hs.90436	9552	ENSG00000091640	sperm associated antigen 7
460	chr17: 4,959,235-4,960,074			GH17J004959
461	chr17: 4,960,446-4,960,595			GH17J004960
462	chr17: 4,965,941-4,971,291			GH17J004965
463	chr17: 4,966,930-4,966,957	-	PIR49988 Exon structure
464	chr17: 4,967,992-4,987,673	-	CAMTA2 Exon structure		Hs.632242	23125	ENSG00000108509	calmodulin binding transcription activator 2
465	chr17: 4,967,995-4,968,822	+	ENSG00000262429 Exon structure				ENSG00000262429
466	chr17: 4,969,702-4,969,771	-	MIR6864 Exon structure			102465521	ENSG00000274300	microRNA 6864
467	chr17: 4,970,086-4,970,150	-	MIR6865 Exon structure			102465522	ENSG00000278517	microRNA 6865
468	chr17: 4,972,638-4,973,800			GH17J004972
469	chr17: 4,972,851-4,974,681	+	ENSG00000234203 Exon structure				ENSG00000234203
470	chr17: 4,974,918-4,975,883			GH17J004974
471	chr17: 4,978,337-4,979,600			GH17J004978
472	chr17: 4,980,166-4,981,105			GH17J004980
473	chr17: 4,985,742-4,989,436			GH17J004985
474	chr17: 4,986,466-4,987,324	+	ENSG00000262678 Exon structure				ENSG00000262678
475	chr17: 4,987,682-4,988,778	+	LOC101927979 Exon structure			101927979	ENSG00000262227
476	chr17: 4,988,130-4,997,922	-	INCA1 Exon structure		Hs.658926	388324	ENSG00000196388	inhibitor of CDK, cyclin A1 interacting protein 1
477	chr17: 4,996,746-5,000,947			GH17J004996
478	chr17: 4,997,948-5,028,401	+	KIF1C Exon structure		Hs.435120	10749	ENSG00000129250	kinesin family member 1C
479	chr17: 5,002,813-5,010,348	-	GC17M005004
480	chr17: 5,012,046-5,012,235			GH17J005012
481	chr17: 5,013,913-5,046,416	+	GC17P005013
482	chr17: 5,016,396-5,017,477			GH17J005016
483	chr17: 5,017,606-5,017,755			GH17J005017
484	chr17: 5,019,214-5,020,093	-	LOC102724009 Exon structure			102724009	ENSG00000227495
485	chr17: 5,025,614-5,031,613	-	LOC105371502 Exon structure			105371502
486	chr17: 5,026,113-5,028,399	+	GC17P005026
487	chr17: 5,030,602-5,032,564			GH17J005030
488	chr17: 5,030,806-5,053,374	+	LOC105371501 Exon structure			105371501
489	chr17: 5,032,600-5,052,009	-	SLC52A1 Exon structure		Hs.632247	55065	ENSG00000132517	solute carrier family 52 member 1
490	chr17: 5,035,201-5,035,800			GH17J005035
491	chr17: 5,041,779-5,043,159			GH17J005041
492	chr17: 5,043,379-5,043,787			GH17J005043
493	chr17: 5,044,086-5,046,420			GH17J005044
494	chr17: 5,047,143-5,047,982			GH17J005047
495	chr17: 5,048,659-5,051,029			GH17J005048
496	chr17: 5,060,356-5,062,305	+	LOC100421332 Exon structure			100421332	ENSG00000262495
497	chr17: 5,062,506-5,062,655			GH17J005062
498	chr17: 5,075,678-5,078,113	-	ENSG00000262693 Exon structure				ENSG00000262693
499	chr17: 5,075,953-5,077,489	-	GC17M005076
500	chr17: 5,077,599-5,079,490			GH17J005077
501	chr17: 5,078,248-5,096,374	+	ZFP3 Exon structure		Hs.48832	124961	ENSG00000180787	ZFP3 zinc finger protein
502	chr17: 5,090,923-5,163,198	+	GC17P005090
503	chr17: 5,092,448-5,092,477	-	PIR60490 Exon structure
504	chr17: 5,093,236-5,093,265	-	PIR55155 Exon structure
505	chr17: 5,093,767-5,093,794	+	PIR45633 Exon structure
506	chr17: 5,096,915-5,098,235			GH17J005096
507	chr17: 5,105,541-5,123,116	-	ZNF232 Exon structure		Hs.279914	7775	ENSG00000167840	zinc finger protein 232
508	chr17: 5,110,936-5,113,011			GH17J005110
509	chr17: 5,111,468-5,115,004	+	LOC101928000 Exon structure			101928000	ENSG00000234327
510	chr17: 5,116,438-5,175,034	+	USP6 Exon structure		Hs.448851	9098	ENSG00000129204	ubiquitin specific peptidase 6
511	chr17: 5,120,076-5,152,612	-	PIRC90 Exon structure			100313798		piwi-interacting RNA cluster 90
512	chr17: 5,120,455-5,121,813			GH17J005120
513	chr17: 5,122,219-5,122,486			GH17J005123
514	chr17: 5,122,371-5,194,742	+	GC17P005122
515	chr17: 5,122,509-5,123,401			GH17J005122
516	chr17: 5,126,740-5,127,010	-	ENSG00000262855 Exon structure				ENSG00000262855
517	chr17: 5,128,111-5,128,744	+	GC17P005128
518	chr17: 5,128,111-5,128,744	+	GC17P005129
519	chr17: 5,128,760-5,128,819			GH17J005128
520	chr17: 5,129,737-5,129,767	-	PIR52864 Exon structure
521	chr17: 5,129,737-5,129,767	-	GC17M005130
522	chr17: 5,130,368-5,130,398	+	PIR47958 Exon structure
523	chr17: 5,130,368-5,130,398	+	GC17P005132
524	chr17: 5,133,932-5,133,958	+	PIR37909 Exon structure
525	chr17: 5,134,960-5,134,990	+	PIR43188 Exon structure
526	chr17: 5,134,960-5,134,990	+	GC17P005135
527	chr17: 5,138,131-5,138,161	+	PIR31193 Exon structure
528	chr17: 5,138,131-5,138,161	+	GC17P005140
529	chr17: 5,138,173-5,138,200	+	PIR55890 Exon structure
530	chr17: 5,165,736-5,166,600			GH17J005165
531	chr17: 5,179,535-5,191,883	-	ZNF594 Exon structure		Hs.658402	84622	ENSG00000180626	zinc finger protein 594
532	chr17: 5,184,366-5,184,515			GH17J005184
533	chr17: 5,191,000-5,192,801			GH17J005191
534	chr17: 5,192,084-5,248,069	+	LOC100130950 Exon structure		Hs.668646	100130950	ENSG00000261879	Uncharacterized LOC100130950 (est)
535	chr17: 5,197,046-5,197,215			GH17J005197
536	chr17: 5,197,686-5,197,835			GH17J005200
537	chr17: 5,198,254-5,199,166			GH17J005198
538	chr17: 5,199,445-5,201,534			GH17J005199
539	chr17: 5,203,986-5,204,115			GH17J005203
540	chr17: 5,207,079-5,207,628			GH17J005207
541	chr17: 5,208,920-5,234,860	-	SCIMP Exon structure		Hs.462080	388325	ENSG00000161929	SLP adaptor and CSK interacting membrane protein
542	chr17: 5,209,506-5,212,411			GH17J005209
543	chr17: 5,215,229-5,215,257	+	PIR60028 Exon structure
544	chr17: 5,219,686-5,219,835			GH17J005219
545	chr17: 5,220,594-5,236,355			GH17J005220
546	chr17: 5,236,746-5,239,280			GH17J005236
547	chr17: 5,239,133-5,242,626	-	GC17M005239
548	chr17: 5,240,508-5,241,543	-	ENSG00000263164 Exon structure				ENSG00000263164
549	chr17: 5,240,919-5,243,792			GH17J005240
550	chr17: 5,245,409-5,248,086	-	GC17M005245
551	chr17: 5,247,831-5,247,859	+	PIR42526 Exon structure
552	chr17: 5,249,095-5,249,339			GH17J005249
553	chr17: 5,249,646-5,249,835			GH17J005250
554	chr17: 5,253,690-5,254,142	+	GC17P005253
555	chr17: 5,254,532-5,256,335			GH17J005254
556	chr17: 5,260,486-5,261,143	+	GC17P005260
557	chr17: 5,264,266-5,264,415			GH17J005264
558	chr17: 5,279,961-5,280,618	+	GC17P005279
559	chr17: 5,281,563-5,284,386			GH17J005281
560	chr17: 5,282,263-5,386,340	+	RABEP1 Exon structure		Hs.592121	9135	ENSG00000029725	rabaptin, RAB GTPase binding effector protein 1
561	chr17: 5,286,498-5,287,578			GH17J005286
562	chr17: 5,288,801-5,289,000			GH17J005288
563	chr17: 5,294,703-5,295,471	-	GC17M005295
564	chr17: 5,299,506-5,299,655			GH17J005299
565	chr17: 5,305,521-5,305,857	-	GC17M005305
566	chr17: 5,306,401-5,307,400			GH17J005306
567	chr17: 5,307,466-5,307,615			GH17J005307
568	chr17: 5,308,086-5,308,400			GH17J005308
569	chr17: 5,309,943-5,311,118	+	GC17P005309
570	chr17: 5,314,006-5,314,155			GH17J005314
571	chr17: 5,329,655-5,330,721			GH17J005329
572	chr17: 5,338,600-5,338,626	+	PIR47423 Exon structure
573	chr17: 5,348,389-5,349,108	-	GC17M005367
574	chr17: 5,354,986-5,355,135			GH17J005354
575	chr17: 5,355,566-5,355,715			GH17J005355
576	chr17: 5,360,961-5,362,905	-	LOC105371505 Exon structure			105371505
577	chr17: 5,360,963-5,420,160	-	NUP88 Exon structure		Hs.584784	4927	ENSG00000108559	nucleoporin 88
578	chr17: 5,361,226-5,361,972			GH17J005361
579	chr17: 5,362,226-5,362,495			GH17J005362
580	chr17: 5,364,315-5,371,626	-	ENSG00000263220 Exon structure				ENSG00000263220
581	chr17: 5,365,966-5,366,115			GH17J005365
582	chr17: 5,367,578-5,369,495			GH17J005367
583	chr17: 5,373,226-5,373,415			GH17J005373
584	chr17: 5,386,257-5,386,316			GH17J005386
585	chr17: 5,386,458-5,610,758	-	GC17M005386
586	chr17: 5,388,610-5,388,636	-	PIR48672 Exon structure
587	chr17: 5,412,183-5,414,780			GH17J005412
588	chr17: 5,414,598-5,431,578	+	GC17P005414
589	chr17: 5,416,589-5,421,312			GH17J005416
590	chr17: 5,419,641-5,433,020	+	RPAIN Exon structure		Hs.462086	84268	ENSG00000129197	RPA interacting protein
591	chr17: 5,422,141-5,423,342			GH17J005422
592	chr17: 5,425,139-5,432,876	-	ENSG00000263272 Exon structure				ENSG00000263272
593	chr17: 5,431,341-5,431,510			GH17J005431
594	chr17: 5,431,572-5,432,645			GH17J005432
595	chr17: 5,432,777-5,448,830	-	C1QBP Exon structure		Hs.555866	708	ENSG00000108561	complement C1q binding protein
596	chr17: 5,437,321-5,440,170			GH17J005437
597	chr17: 5,440,912-5,469,060	-	DHX33 Exon structure		Hs.250456	56919	ENSG00000005100	DEAH-box helicase 33
598	chr17: 5,441,228-5,441,287			GH17J005441
599	chr17: 5,441,798-5,441,857			GH17J005442
600	chr17: 5,464,770-5,466,042			GH17J005464
601	chr17: 5,466,745-5,469,700			GH17J005466
602	chr17: 5,469,057-5,470,392	+	LOC105371506 Exon structure			105371506	ENSG00000262099
603	chr17: 5,471,251-5,486,811	-	DERL2 Exon structure		Hs.286131	51009	ENSG00000072849	derlin 2
604	chr17: 5,471,257-5,473,238	-	GC17M005472
605	chr17: 5,480,236-5,482,655	-	GC17M005480
606	chr17: 5,484,882-5,488,026			GH17J005484
607	chr17: 5,486,285-5,490,814	+	MIS12 Exon structure		Hs.267194	79003	ENSG00000167842	MIS12, kinetochore complex component
608	chr17: 5,499,427-5,500,999	-	LOC728392 Exon structure		Hs.104305	728392		Uncharacterized LOC728392 (est)
609	chr17: 5,499,427-5,619,424	-	NLRP1 Exon structure		Hs.652273	22861	ENSG00000091592	NLR family pyrin domain containing 1
610	chr17: 5,499,652-5,501,833			GH17J005499
611	chr17: 5,502,001-5,502,150			GH17J005502
612	chr17: 5,508,852-5,510,374			GH17J005508
613	chr17: 5,511,521-5,511,615			GH17J005511
614	chr17: 5,511,843-5,513,323	-	LOC101928044 Exon structure			101928044	ENSG00000282980
615	chr17: 5,513,542-5,514,304			GH17J005513
616	chr17: 5,514,208-5,514,258	-	GC17M005515
617	chr17: 5,514,210-5,514,270	-	RNU7-31P Exon structure			100147818		RNA, U7 small nuclear 31 pseudogene
618	chr17: 5,514,341-5,514,390			GH17J005514
619	chr17: 5,514,930-5,518,182			GH17J005515
620	chr17: 5,525,472-5,528,621			GH17J005525
621	chr17: 5,539,697-5,554,775	+	LOC105371507 Exon structure			105371507
622	chr17: 5,545,078-5,545,294			GH17J005545
623	chr17: 5,551,877-5,552,117			GH17J005551
624	chr17: 5,554,824-5,556,124			GH17J005554
625	chr17: 5,557,561-5,557,730			GH17J005557
626	chr17: 5,580,501-5,580,650			GH17J005580
627	chr17: 5,582,259-5,586,665			GH17J005582
628	chr17: 5,587,561-5,587,710			GH17J005587
629	chr17: 5,610,775-5,611,600			GH17J005610
630	chr17: 5,619,414-5,619,473			GH17J005619
631	chr17: 5,630,146-5,631,250			GH17J005630
632	chr17: 5,694,581-5,694,750			GH17J005694
633	chr17: 5,695,621-5,695,770			GH17J005695
634	chr17: 5,699,082-5,700,143			GH17J005699
635	chr17: 5,705,181-5,705,330			GH17J005705
636	chr17: 5,706,941-5,707,110			GH17J005706
637	chr17: 5,711,521-5,711,670			GH17J005711
638	chr17: 5,717,801-5,717,950			GH17J005717
639	chr17: 5,718,674-5,718,685			GH17J005718
640	chr17: 5,730,289-5,731,808	+	LOC100128284 Exon structure			100128284	ENSG00000262961
641	chr17: 5,758,775-5,758,970			GH17J005758
642	chr17: 5,759,387-5,760,403			GH17J005759
643	chr17: 5,769,534-5,771,200			GH17J005769
644	chr17: 5,772,234-5,930,696	+	LOC339166 Exon structure		Hs.736088	339166	ENSG00000284837	Uncharacterized LOC339166 (est)
645	chr17: 5,772,926-6,080,792	+	ENSG00000285471 Exon structure				ENSG00000285471
646	chr17: 5,782,301-5,782,430			GH17J005782
647	chr17: 5,784,941-5,786,852			GH17J005784
648	chr17: 5,813,441-5,813,590			GH17J005813
649	chr17: 5,823,308-5,823,339	+	GC17P005823
650	chr17: 5,825,341-5,826,121			GH17J005825
651	chr17: 5,826,501-5,826,690			GH17J005826
652	chr17: 5,827,762-5,831,410	-	GC17M005827
653	chr17: 5,831,972-5,837,910			GH17J005831
654	chr17: 5,883,901-5,884,050			GH17J005883
655	chr17: 5,884,501-5,884,650			GH17J005884
656	chr17: 5,896,999-5,898,132			GH17J005896
657	chr17: 5,918,921-5,919,806			GH17J005918
658	chr17: 5,942,933-5,942,956			GH17J005942
659	chr17: 5,951,258-5,951,363			GH17J005951
660	chr17: 5,957,837-5,957,863	+	PIR60431 Exon structure
661	chr17: 5,970,016-5,974,359	-	GC17M005970
662	chr17: 6,002,239-6,004,155			GH17J006002
663	chr17: 6,020,141-6,021,339			GH17J006020
664	chr17: 6,022,628-6,023,745			GH17J006022
665	chr17: 6,047,615-6,048,609			GH17J006047
666	chr17: 6,057,807-6,124,427	+	WSCD1 Exon structure		Hs.370166	23302	ENSG00000179314	WSC domain containing 1
667	chr17: 6,061,046-6,062,146			GH17J006061
668	chr17: 6,069,041-6,069,190			GH17J006069
669	chr17: 6,070,200-6,071,201			GH17J006070
670	chr17: 6,071,241-6,071,390			GH17J006072
671	chr17: 6,071,942-6,072,575			GH17J006071
672	chr17: 6,074,695-6,075,963			GH17J006074
673	chr17: 6,077,910-6,080,501			GH17J006077
674	chr17: 6,080,699-6,080,758			GH17J006080
675	chr17: 6,083,276-6,085,814			GH17J006083
676	chr17: 6,087,564-6,088,211	-	GC17M006087
677	chr17: 6,091,486-6,093,333			GH17J006091
678	chr17: 6,096,815-6,099,910			GH17J006096
679	chr17: 6,101,266-6,102,750			GH17J006101
680	chr17: 6,102,821-6,102,970			GH17J006102
681	chr17: 6,110,681-6,110,830			GH17J006110
682	chr17: 6,130,580-6,130,607	+	PIR32157 Exon structure
683	chr17: 6,138,621-6,139,521			GH17J006138
684	chr17: 6,139,612-6,140,283			GH17J006139
685	chr17: 6,149,980-6,190,547	-	LOC105371508 Exon structure			105371508	ENSG00000262231
686	chr17: 6,162,106-6,162,722			GH17J006162
687	chr17: 6,177,964-6,180,097			GH17J006177
688	chr17: 6,187,521-6,188,490			GH17J006187
689	chr17: 6,207,162-6,207,269	+	GC17P006208
690	chr17: 6,207,163-6,207,269	+	RNU6-1264P Exon structure			106480117	ENSG00000206618	RNA, U6 small nuclear 1264, pseudogene
691	chr17: 6,229,278-6,243,304	-	GC17M006229
692	chr17: 6,232,001-6,232,784			GH17J006232
693	chr17: 6,238,117-6,238,754			GH17J006238
694	chr17: 6,241,501-6,241,690			GH17J006241
695	chr17: 6,256,641-6,258,240			GH17J006256
696	chr17: 6,322,413-6,323,228	-	BTF3P14 Exon structure			100132641	ENSG00000262609	basic transcription factor 3 pseudogene 14
697	chr17: 6,322,413-6,324,718	-	GC17M006323
698	chr17: 6,326,641-6,328,694			GH17J006326
699	chr17: 6,342,519-6,375,012	-	LOC105371509 Exon structure			105371509
700	chr17: 6,347,679-6,349,742			GH17J006347
701	chr17: 6,361,861-6,361,990			GH17J006361
702	chr17: 6,364,585-6,366,622			GH17J006364
703	chr17: 6,374,115-6,375,489			GH17J006374
704	chr17: 6,380,594-6,385,366			GH17J006380
705	chr17: 6,387,203-6,389,392			GH17J006387
706	chr17: 6,392,721-6,392,870			GH17J006392
707	chr17: 6,393,441-6,393,550			GH17J006393
708	chr17: 6,393,693-6,435,199	-	AIPL1 Exon structure		Hs.279887	23746	ENSG00000129221	aryl hydrocarbon receptor interacting protein like 1
709	chr17: 6,394,141-6,394,150			GH17J006394
710	chr17: 6,417,685-6,418,264	+	ENSG00000262818 Exon structure				ENSG00000262818
711	chr17: 6,420,301-6,420,438			GH17J006420
712	chr17: 6,420,441-6,420,590			GH17J006421
713	chr17: 6,422,081-6,422,290			GH17J006422
714	chr17: 6,427,401-6,428,200			GH17J006427
715	chr17: 6,429,328-6,429,674			GH17J006429
716	chr17: 6,435,110-6,435,262	-	GC17M006435
717	chr17: 6,435,110-6,435,262	-	GC17M006436
718	chr17: 6,435,110-6,435,169			GH17J006435
719	chr17: 6,436,101-6,436,210			GH17J006436
720	chr17: 6,437,109-6,437,355			GH17J006437
721	chr17: 6,437,641-6,437,810			GH17J006438
722	chr17: 6,439,721-6,440,472			GH17J006439
723	chr17: 6,443,225-6,445,239			GH17J006443
724	chr17: 6,444,205-6,451,469	+	PIMREG Exon structure		Hs.592116	54478	ENSG00000129195	PICALM interacting mitotic regulator
725	chr17: 6,450,344-6,556,557	-	PITPNM3 Exon structure		Hs.183983	83394	ENSG00000091622	PITPNM family member 3
726	chr17: 6,451,141-6,451,881			GH17J006451
727	chr17: 6,452,363-6,452,392	-	PIR59695 Exon structure
728	chr17: 6,454,221-6,455,819			GH17J006454
729	chr17: 6,456,253-6,456,281	-	PIR59656 Exon structure
730	chr17: 6,456,348-6,458,699			GH17J006456
731	chr17: 6,460,818-6,568,382	-	GC17M006460
732	chr17: 6,461,323-6,462,349			GH17J006461
733	chr17: 6,464,038-6,464,852			GH17J006464
734	chr17: 6,470,701-6,470,850			GH17J006470
735	chr17: 6,471,356-6,472,746			GH17J006471
736	chr17: 6,473,000-6,473,601			GH17J006473
737	chr17: 6,474,365-6,477,613			GH17J006474
738	chr17: 6,477,866-6,478,566			GH17J006477
739	chr17: 6,482,022-6,482,915			GH17J006482
740	chr17: 6,483,311-6,485,220			GH17J006483
741	chr17: 6,485,316-6,489,849			GH17J006485
742	chr17: 6,489,888-6,490,958			GH17J006489
743	chr17: 6,490,156-6,490,183	+	PIR55314 Exon structure
744	chr17: 6,491,041-6,491,110			GH17J006491
745	chr17: 6,493,001-6,493,150			GH17J006493
746	chr17: 6,495,566-6,496,621			GH17J006495
747	chr17: 6,496,801-6,498,474			GH17J006496
748	chr17: 6,501,111-6,505,191			GH17J006501
749	chr17: 6,505,468-6,511,430			GH17J006505
750	chr17: 6,511,882-6,513,290			GH17J006511
751	chr17: 6,516,597-6,517,792			GH17J006516
752	chr17: 6,521,131-6,521,412	+	ENSG00000274860 Exon structure				ENSG00000274860
753	chr17: 6,523,238-6,523,563	+	GC17P006523
754	chr17: 6,523,238-6,523,563	+	GC17P006524
755	chr17: 6,523,441-6,523,630			GH17J006523
756	chr17: 6,524,308-6,524,956	+	GC17P006525
757	chr17: 6,524,621-6,524,647			GH17J006524
758	chr17: 6,532,451-6,532,709			GH17J006532
759	chr17: 6,533,716-6,539,365			GH17J006533
760	chr17: 6,542,463-6,544,623			GH17J006542
761	chr17: 6,544,718-6,546,711			GH17J006544
762	chr17: 6,546,895-6,547,833			GH17J006546
763	chr17: 6,548,269-6,549,549			GH17J006548
764	chr17: 6,549,970-6,550,279			GH17J006549
765	chr17: 6,550,310-6,551,176			GH17J006550
766	chr17: 6,551,401-6,553,879			GH17J006551
767	chr17: 6,554,461-6,556,801			GH17J006554
768	chr17: 6,557,950-6,560,382			GH17J006557
769	chr17: 6,566,881-6,568,409			GH17J006566
770	chr17: 6,570,624-6,571,895			GH17J006570
771	chr17: 6,574,755-6,576,531			GH17J006574
772	chr17: 6,578,081-6,579,202			GH17J006578
773	chr17: 6,578,148-6,641,744	-	KIAA0753 Exon structure		Hs.28070	9851	ENSG00000198920	KIAA0753
774	chr17: 6,589,044-6,590,925			GH17J006589
775	chr17: 6,591,141-6,592,738			GH17J006591
776	chr17: 6,599,041-6,600,200			GH17J006599
777	chr17: 6,600,943-6,601,051	-	GC17M006601
778	chr17: 6,600,944-6,601,051	-	RNA5SP435 Exon structure			106479013	ENSG00000200914	RNA, 5S ribosomal pseudogene 435
779	chr17: 6,611,333-6,612,099			GH17J006611
780	chr17: 6,636,780-6,640,316	-	ENSG00000282936 Exon structure				ENSG00000282936
781	chr17: 6,637,877-6,644,232			GH17J006637
782	chr17: 6,639,031-6,639,057	-	PIR46953 Exon structure
783	chr17: 6,639,124-6,639,154	-	PIR43569 Exon structure
784	chr17: 6,639,124-6,639,154	-	GC17M006641
785	chr17: 6,640,758-6,644,541	+	TXNDC17 Exon structure		Hs.408236	84817	ENSG00000129235	thioredoxin domain containing 17
786	chr17: 6,640,985-6,643,123	+	GC17P006641
787	chr17: 6,643,313-6,651,634	-	MED31 Exon structure		Hs.567493	51003	ENSG00000108590	mediator complex subunit 31
788	chr17: 6,649,932-6,653,077			GH17J006649
789	chr17: 6,651,718-6,693,202	+	C17orf100 Exon structure		Hs.262480	388327	ENSG00000256806	chromosome 17 open reading frame 100
790	chr17: 6,652,539-6,652,567	+	PIR47256 Exon structure
791	chr17: 6,653,464-6,655,009	-	ENSG00000261996 Exon structure				ENSG00000261996
792	chr17: 6,654,201-6,658,200			GH17J006654
793	chr17: 6,655,440-6,655,509	-	MIR4520-1 Exon structure			100616401	ENSG00000264468	microRNA 4520-1
794	chr17: 6,655,449-6,655,502	+	MIR4520-2 Exon structure			100616466	ENSG00000283301	microRNA 4520-2
795	chr17: 6,657,719-6,661,382	+	ALOX15P1 Exon structure		Hs.549540	100652883	ENSG00000274114	arachidonate 15-lipoxygenase pseudogene 1
796	chr17: 6,660,201-6,661,800			GH17J006660
797	chr17: 6,666,102-6,666,451			GH17J006666
798	chr17: 6,668,750-6,671,908			GH17J006668
799	chr17: 6,672,221-6,672,249	+	PIR54331 Exon structure
800	chr17: 6,672,221-6,672,249	+	GC17P006673
801	chr17: 6,684,713-6,713,567	-	SLC13A5 Exon structure		Hs.399496	284111	ENSG00000141485	solute carrier family 13 member 5
802	chr17: 6,684,723-6,690,082	-	GC17M006685
803	chr17: 6,699,684-6,701,451			GH17J006699
804	chr17: 6,701,842-6,701,991			GH17J006701
805	chr17: 6,710,382-6,710,531			GH17J006711
806	chr17: 6,710,608-6,714,432			GH17J006710
807	chr17: 6,749,685-6,749,978	-	ENSG00000262990 Exon structure				ENSG00000262990
808	chr17: 6,749,718-6,750,188	+	RPL23AP73 Exon structure			100271625	ENSG00000244283	ribosomal protein L23a pseudogene 73
809	chr17: 6,751,604-6,754,297			GH17J006751
810	chr17: 6,754,608-6,757,520			GH17J006754
811	chr17: 6,755,447-6,775,647	+	XAF1 Exon structure		Hs.441975	54739	ENSG00000132530	XIAP associated factor 1
812	chr17: 6,757,801-6,758,000			GH17J006757
813	chr17: 6,772,831-6,776,116	-	PRAL Exon structure			109245082	ENSG00000279296	p53 regulation associated lncRNA
814	chr17: 6,776,166-6,776,225			GH17J006776
815	chr17: 6,776,175-6,797,101	+	FBXO39 Exon structure		Hs.368364	162517	ENSG00000177294	F-box protein 39
816	chr17: 6,786,538-6,787,446			GH17J006786
817	chr17: 6,789,133-6,831,761	-	TEKT1 Exon structure		Hs.462108	83659	ENSG00000167858	tektin 1
818	chr17: 6,795,751-6,797,664			GH17J006795
819	chr17: 6,800,542-6,800,691			GH17J006800
820	chr17: 6,822,690-6,823,770			GH17J006822
821	chr17: 6,831,469-6,832,260			GH17J006831
822	chr17: 6,843,382-6,843,531			GH17J006843
823	chr17: 6,853,322-6,856,000			GH17J006853
824	chr17: 6,853,576-6,954,107	+	ALOX12P2 Exon structure		Hs.378695	245	ENSG00000262943	arachidonate 12-lipoxygenase pseudogene 2
825	chr17: 6,863,383-6,863,916	-	GC17M006868
826	chr17: 6,867,332-6,869,842			GH17J006867
827	chr17: 6,871,372-6,873,509			GH17J006871
828	chr17: 6,876,635-7,012,349	-	ALOX12-AS1 Exon structure		Hs.422967	100506713	ENSG00000215067	ALOX12 antisense RNA 1
829	chr17: 6,887,328-6,887,556			GH17J006887
830	chr17: 6,894,302-6,894,431			GH17J006894
831	chr17: 6,901,058-6,902,359	+	GC17P006901
832	chr17: 6,907,342-6,907,491			GH17J006907
833	chr17: 6,911,668-6,912,059			GH17J006911
834	chr17: 6,913,682-6,914,600			GH17J006913
835	chr17: 6,919,560-6,919,946			GH17J006919
836	chr17: 6,925,969-6,926,242			GH17J006925
837	chr17: 6,927,417-6,928,228	-	LOC100128007 Exon structure			100128007	ENSG00000262503
838	chr17: 6,927,472-6,928,191	-	GC17M006933
839	chr17: 6,936,201-6,937,199			GH17J006936
840	chr17: 6,940,281-6,940,799			GH17J006940
841	chr17: 6,948,550-6,949,001			GH17J006948
842	chr17: 6,954,098-6,978,960	-	ENSG00000263316 Exon structure				ENSG00000263316
843	chr17: 6,958,663-6,961,078	-	GC17M006958
844	chr17: 6,976,711-6,977,265	-	GC17M006978
845	chr17: 6,980,856-6,981,165	-	GC17M006980
846	chr17: 6,985,494-7,019,414	-	ENSG00000267047 Exon structure				ENSG00000267047
847	chr17: 6,993,355-6,997,130			GH17J006993
848	chr17: 6,994,196-7,010,754	+	ALOX12 Exon structure		Hs.654431	239	ENSG00000108839	arachidonate 12-lipoxygenase, 12S type
849	chr17: 6,994,642-6,995,189	-	ENSG00000262089 Exon structure				ENSG00000262089
850	chr17: 6,998,620-6,999,481			GH17J006998
851	chr17: 7,001,722-7,001,871			GH17J007001
852	chr17: 7,004,106-7,004,350	-	GC17M007005
853	chr17: 7,004,882-7,005,051			GH17J007004
854	chr17: 7,007,691-7,013,286	-	GC17M007007
855	chr17: 7,010,863-7,024,564			GH17J007010
856	chr17: 7,012,417-7,017,524	+	RNASEK-C17orf49 Exon structure			100529209	ENSG00000161939	RNASEK-C17orf49 readthrough
857	chr17: 7,012,417-7,014,533	+	RNASEK Exon structure		Hs.632232	440400	ENSG00000219200	ribonuclease K
858	chr17: 7,014,495-7,017,525	+	C17orf49 Exon structure		Hs.511801	124944	ENSG00000258315	chromosome 17 open reading frame 49
859	chr17: 7,015,818-7,019,659	-	MIR497HG Exon structure		Hs.710442	100506755	ENSG00000267532	mir-497-195 cluster host gene
860	chr17: 7,017,615-7,017,701	-	MIR195 Exon structure			406971	ENSG00000284112	microRNA 195
861	chr17: 7,017,911-7,018,022	-	MIR497 Exon structure			574456	ENSG00000284027	microRNA 497
862	chr17: 7,023,020-7,030,290	+	BCL6B Exon structure		Hs.22575	255877	ENSG00000161940	B cell CLL/lymphoma 6B
863	chr17: 7,027,402-7,030,637			GH17J007027
864	chr17: 7,032,365-7,032,395	+	PIR37276 Exon structure
865	chr17: 7,032,365-7,032,395	+	GC17P007033
866	chr17: 7,032,365-7,032,395	+	GC17P007034
867	chr17: 7,032,365-7,032,395	+	GC17P007035
868	chr17: 7,034,805-7,037,185			GH17J007034
869	chr17: 7,035,171-7,035,430	-	GC17M007037
870	chr17: 7,036,075-7,040,121	+	SLC16A13 Exon structure		Hs.448010	201232	ENSG00000174327	solute carrier family 16 member 13
871	chr17: 7,036,097-7,037,064	+	GC17P007037
872	chr17: 7,037,941-7,039,931			GH17J007037
873	chr17: 7,039,942-7,040,091			GH17J007039
874	chr17: 7,041,293-7,044,222			GH17J007041
875	chr17: 7,041,617-7,044,400	-	SLC16A11 Exon structure		Hs.336564	162515	ENSG00000174326	solute carrier family 16 member 11
876	chr17: 7,045,362-7,047,879			GH17J007045
877	chr17: 7,052,000-7,052,401			GH17J007052
878	chr17: 7,058,847-7,059,114			GH17J007058
879	chr17: 7,058,934-7,059,204	+	ENSG00000262067 Exon structure				ENSG00000262067
880	chr17: 7,059,179-7,060,077	-	GC17M007059
881	chr17: 7,059,182-7,059,331			GH17J007060
882	chr17: 7,059,975-7,061,550			GH17J007059
883	chr17: 7,065,583-7,065,610	-	PIR51267 Exon structure
884	chr17: 7,074,537-7,080,601	-	CLEC10A Exon structure		Hs.54403	10462	ENSG00000132514	C-type lectin domain containing 10A
885	chr17: 7,079,001-7,080,600			GH17J007079
886	chr17: 7,084,201-7,084,600			GH17J007084
887	chr17: 7,091,340-7,091,370	+	PIR50426 Exon structure
888	chr17: 7,091,340-7,091,370	+	GC17P007091
889	chr17: 7,091,340-7,091,370	+	GC17P007092
890	chr17: 7,091,340-7,091,370	+	GC17P007093
891	chr17: 7,091,340-7,091,370	+	GC17P007094
892	chr17: 7,091,340-7,091,370	+	GC17P007095
893	chr17: 7,091,340-7,091,370	+	GC17P007101
894	chr17: 7,091,401-7,092,000			GH17J007091
895	chr17: 7,093,801-7,095,014			GH17J007093
896	chr17: 7,095,294-7,096,210			GH17J007095
897	chr17: 7,099,125-7,099,266			GH17J007099
898	chr17: 7,101,322-7,115,700	-	ASGR2 Exon structure		Hs.654440	433	ENSG00000161944	asialoglycoprotein receptor 2
899	chr17: 7,101,377-7,102,410			GH17J007101
900	chr17: 7,109,601-7,110,000			GH17J007109
901	chr17: 7,112,054-7,113,020			GH17J007112
902	chr17: 7,113,201-7,116,336			GH17J007113
903	chr17: 7,120,383-7,122,084			GH17J007120
904	chr17: 7,122,201-7,122,600			GH17J007122
905	chr17: 7,129,801-7,130,000			GH17J007129
906	chr17: 7,130,223-7,134,200			GH17J007130
907	chr17: 7,131,264-7,140,890	+	LOC105371512 Exon structure			105371512
908	chr17: 7,135,489-7,139,800			GH17J007135
909	chr17: 7,140,930-7,141,592	+	RPL7AP64 Exon structure			728486	ENSG00000213876	ribosomal protein L7a pseudogene 64
910	chr17: 7,141,233-7,142,524			GH17J007141
911	chr17: 7,141,781-7,142,438	-	GC17M007141
912	chr17: 7,146,282-7,146,431			GH17J007146
913	chr17: 7,168,401-7,169,200			GH17J007168
914	chr17: 7,169,601-7,170,400			GH17J007169
915	chr17: 7,170,801-7,171,400			GH17J007170
916	chr17: 7,171,601-7,175,759			GH17J007171
917	chr17: 7,173,431-7,179,564	-	ASGR1 Exon structure		Hs.12056	432	ENSG00000141505	asialoglycoprotein receptor 1
918	chr17: 7,176,763-7,195,104	+	GC17P007176
919	chr17: 7,177,002-7,178,695			GH17J007177
920	chr17: 7,179,360-7,179,419			GH17J007179
921	chr17: 7,183,805-7,184,851			GH17J007183
922	chr17: 7,189,890-7,220,050	-	DLG4 Exon structure		Hs.463928	1742	ENSG00000132535	discs large MAGUK scaffold protein 4
923	chr17: 7,191,602-7,191,771			GH17J007191
924	chr17: 7,192,295-7,192,448	-	ENSG00000279812 Exon structure				ENSG00000279812
925	chr17: 7,192,304-7,192,363			GH17J007192
926	chr17: 7,203,553-7,209,274			GH17J007203
927	chr17: 7,211,235-7,212,400			GH17J007211
928	chr17: 7,213,402-7,223,977			GH17J007213
929	chr17: 7,214,505-7,217,835	-	GC17M007214
930	chr17: 7,217,125-7,225,273	+	ACADVL Exon structure		Hs.437178	37	ENSG00000072778	acyl-CoA dehydrogenase very long chain
931	chr17: 7,219,860-7,220,922	+	GC17P007220
932	chr17: 7,223,297-7,223,379	-	MIR324 Exon structure			442898	ENSG00000199053	microRNA 324
933	chr17: 7,223,341-7,223,364	-	GC17M007224
934	chr17: 7,224,716-7,225,571			GH17J007224
935	chr17: 7,225,341-7,234,548	-	DVL2 Exon structure		Hs.118640	1856	ENSG00000004975	dishevelled segment polarity protein 2
936	chr17: 7,228,462-7,228,611			GH17J007228
937	chr17: 7,229,059-7,230,054	+	GC17P007229
938	chr17: 7,233,000-7,244,317			GH17J007233
939	chr17: 7,233,224-7,233,306	-	GC17M007238
940	chr17: 7,235,028-7,239,722	-	PHF23 Exon structure		Hs.644724	79142	ENSG00000040633	PHD finger protein 23
941	chr17: 7,240,014-7,242,770	-	GABARAP Exon structure		Hs.647421	11337	ENSG00000170296	GABA type A receptor-associated protein
942	chr17: 7,240,427-7,244,635	-	ENSG00000262526 Exon structure				ENSG00000262526
943	chr17: 7,242,200-7,243,814	+	ENSG00000279641 Exon structure				ENSG00000279641
944	chr17: 7,243,587-7,252,491	-	CTDNEP1 Exon structure		Hs.513913	23399	ENSG00000175826	CTD nuclear envelope phosphatase 1
945	chr17: 7,246,829-7,262,089	-	ENSG00000262302 Exon structure				ENSG00000262302
946	chr17: 7,247,656-7,253,700			GH17J007247
947	chr17: 7,249,729-7,259,370	-	GC17M007249
948	chr17: 7,251,416-7,259,940	+	ELP5 Exon structure		Hs.417029	23587	ENSG00000170291	elongator acetyltransferase complex subunit 5
949	chr17: 7,252,544-7,252,573	+	PIR48144 Exon structure
950	chr17: 7,256,430-7,265,165			GH17J007256
951	chr17: 7,259,622-7,259,648	+	PIR33341 Exon structure
952	chr17: 7,259,903-7,263,983	-	CLDN7 Exon structure		Hs.513915	1366	ENSG00000181885	claudin 7
953	chr17: 7,266,055-7,266,166	-	ENSG00000202251 Exon structure				ENSG00000202251
954	chr17: 7,266,056-7,266,166	-	GC17M007267
955	chr17: 7,266,200-7,266,600			GH17J007267
956	chr17: 7,266,707-7,267,099	+	GC17P007268
957	chr17: 7,266,708-7,267,026			GH17J007266
958	chr17: 7,268,722-7,269,666			GH17J007268
959	chr17: 7,279,181-7,283,494			GH17J007279
960	chr17: 7,281,667-7,288,257	+	SLC2A4 Exon structure		Hs.380691	6517	ENSG00000181856	solute carrier family 2 member 4
961	chr17: 7,282,947-7,284,071	-	ENSG00000263342 Exon structure				ENSG00000263342
962	chr17: 7,288,252-7,294,615	-	YBX2 Exon structure		Hs.567494	51087	ENSG00000006047	Y-box binding protein 2
963	chr17: 7,288,520-7,288,546	-	PIR37783 Exon structure
964	chr17: 7,293,184-7,297,067			GH17J007293
965	chr17: 7,293,495-7,293,526	-	PIR50100 Exon structure
966	chr17: 7,293,495-7,293,526	-	GC17M007298
967	chr17: 7,293,495-7,293,526	-	GC17M007299
968	chr17: 7,306,076-7,311,195			GH17J007306
969	chr17: 7,306,999-7,312,463	+	EIF5A Exon structure		Hs.534314	1984	ENSG00000132507	eukaryotic translation initiation factor 5A
970	chr17: 7,309,693-7,309,722	+	PIR44947 Exon structure
971	chr17: 7,311,324-7,315,564	-	GPS2 Exon structure		Hs.438219	2874	ENSG00000132522	G protein pathway suppressor 2
972	chr17: 7,311,355-7,311,385	-	GC17M007313
973	chr17: 7,312,545-7,316,544			GH17J007312
974	chr17: 7,312,661-7,319,174	-	ENSG00000261915 Exon structure				ENSG00000261915
975	chr17: 7,313,355-7,313,940	-	GC17M007314
976	chr17: 7,315,628-7,329,393	-	NEURL4 Exon structure		Hs.654794	84461	ENSG00000215041	neuralized E3 ubiquitin protein ligase 4
977	chr17: 7,317,267-7,317,326			GH17J007319
978	chr17: 7,317,602-7,317,661			GH17J007317
979	chr17: 7,317,989-7,319,353			GH17J007318
980	chr17: 7,324,282-7,324,511			GH17J007324
981	chr17: 7,328,183-7,331,264			GH17J007328
982	chr17: 7,330,452-7,335,413	+	ENSG00000224647 Exon structure				ENSG00000224647
983	chr17: 7,331,773-7,333,311			GH17J007331
984	chr17: 7,332,575-7,336,301	-	GC17M007332
985	chr17: 7,334,718-7,338,205			GH17J007334
986	chr17: 7,336,511-7,351,478	+	ACAP1 Exon structure		Hs.337242	9744	ENSG00000072818	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
987	chr17: 7,345,331-7,350,228	+	GC17P007352
988	chr17: 7,345,962-7,346,111			GH17J007345
989	chr17: 7,347,306-7,356,331			GH17J007347
990	chr17: 7,351,889-7,354,944	+	KCTD11 Exon structure		Hs.592112	147040	ENSG00000213859	potassium channel tetramerization domain containing 11
991	chr17: 7,351,890-7,352,700	+	GC17P007353
992	chr17: 7,352,687-7,354,944	-	ENSG00000263171 Exon structure				ENSG00000263171
993	chr17: 7,355,123-7,357,219	+	TMEM95 Exon structure		Hs.259432	339168	ENSG00000182896	transmembrane protein 95
994	chr17: 7,356,342-7,356,491			GH17J007356
995	chr17: 7,361,727-7,362,628			GH17J007361
996	chr17: 7,361,991-7,363,123	+	GC17P007361
997	chr17: 7,363,422-7,363,571			GH17J007363
998	chr17: 7,368,037-7,368,134			GH17J007368
999	chr17: 7,368,262-7,368,471			GH17J007370
1000	chr17: 7,368,522-7,368,671			GH17J007369
1001	chr17: 7,380,462-7,381,880			GH17J007380
1002	chr17: 7,380,534-7,389,774	+	TNK1 Exon structure		Hs.203420	8711	ENSG00000174292	tyrosine kinase non receptor 1
1003	chr17: 7,383,642-7,385,013			GH17J007383
1004	chr17: 7,389,727-7,404,131	-	TMEM256-PLSCR3 Exon structure			100529211	ENSG00000262481	TMEM256-PLSCR3 readthrough (NMD candidate)
1005	chr17: 7,389,727-7,394,843	-	PLSCR3 Exon structure		Hs.534591	57048	ENSG00000187838	phospholipid scramblase 3
1006	chr17: 7,390,256-7,390,315			GH17J007390
1007	chr17: 7,393,280-7,395,482			GH17J007393
1008	chr17: 7,399,762-7,400,603			GH17J007399
1009	chr17: 7,400,822-7,400,931			GH17J007400
1010	chr17: 7,401,720-7,406,531			GH17J007401
1011	chr17: 7,402,974-7,404,137	-	TMEM256 Exon structure		Hs.730789	254863	ENSG00000205544	transmembrane protein 256
1012	chr17: 7,404,874-7,419,864	+	NLGN2 Exon structure		Hs.26229	57555	ENSG00000169992	neuroligin 2
1013	chr17: 7,407,009-7,409,835	-	GC17M007407
1014	chr17: 7,408,126-7,408,185			GH17J007408
1015	chr17: 7,412,963-7,414,053			GH17J007412
1016	chr17: 7,420,103-7,444,081	+	ENSG00000262880 Exon structure				ENSG00000262880
1017	chr17: 7,420,282-7,420,341			GH17J007420
1018	chr17: 7,420,360-7,421,632	+	SPEM1 Exon structure		Hs.710599	374768	ENSG00000181323	spermatid maturation 1
1019	chr17: 7,424,881-7,427,568	+	SPEM2 Exon structure		Hs.380704	201243	ENSG00000184560	SPEM family member 2
1020	chr17: 7,425,567-7,425,626			GH17J007425
1021	chr17: 7,428,825-7,437,679	+	TMEM102 Exon structure		Hs.655662	284114	ENSG00000181284	transmembrane protein 102
1022	chr17: 7,428,863-7,432,762	+	SPEM3 Exon structure			107983988	ENSG00000283439	SPEM family member 3
1023	chr17: 7,434,722-7,438,747			GH17J007434
1024	chr17: 7,436,557-7,437,523	-	ENSG00000262624 Exon structure				ENSG00000262624
1025	chr17: 7,438,273-7,444,937	+	FGF11 Exon structure		Hs.655193	2256	ENSG00000161958	fibroblast growth factor 11
1026	chr17: 7,438,935-7,438,994			GH17J007438
1027	chr17: 7,439,159-7,443,327	-	ENSG00000263301 Exon structure				ENSG00000263301
1028	chr17: 7,439,463-7,441,627			GH17J007439
1029	chr17: 7,439,506-7,445,966	+	ENSG00000272884 Exon structure				ENSG00000272884
1030	chr17: 7,442,992-7,446,371			GH17J007442
1031	chr17: 7,445,061-7,457,707	+	CHRNB1 Exon structure		Hs.330386	1140	ENSG00000170175	cholinergic receptor nicotinic beta 1 subunit
1032	chr17: 7,450,170-7,452,635			GH17J007450
1033	chr17: 7,454,962-7,456,999			GH17J007454
1034	chr17: 7,459,366-7,484,263	-	ZBTB4 Exon structure		Hs.35096	57659	ENSG00000174282	zinc finger and BTB domain containing 4
1035	chr17: 7,460,922-7,461,071			GH17J007460
1036	chr17: 7,461,083-7,461,255			GH17J007462
1037	chr17: 7,461,362-7,461,531			GH17J007461
1038	chr17: 7,462,645-7,462,674	-	PIR46408 Exon structure
1039	chr17: 7,463,765-7,463,797	-	PIR45545 Exon structure
1040	chr17: 7,463,765-7,463,797	-	GC17M007464
1041	chr17: 7,465,945-7,468,109			GH17J007465
1042	chr17: 7,470,649-7,471,317			GH17J007470
1043	chr17: 7,472,001-7,472,200			GH17J007472
1044	chr17: 7,474,332-7,486,846			GH17J007474
1045	chr17: 7,476,719-7,476,745	-	PIR47282 Exon structure
1046	chr17: 7,481,332-7,483,496	+	SLC35G6 Exon structure		Hs.632234	643664	ENSG00000259224	solute carrier family 35 member G6

GeneLoc map region for Chromosome 17 (3,486,285 - 7,490,814 bp) around "MIS12"